DMAC vs WMT · $157.4M cap vs P/E 42, rev $713.16B
DiaMedica Therapeutics Inc (DMAC) versus Walmart Inc (WMT) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Walmart Inc (WMT) is a discount stores company listed on US. It is led by Doug McMillon.
DMAC does not have a complete income-statement cache yet.
Latest reported WMT revenue for 2026-01-31 was $713.16B. Net income was $21.89B. Revenue was up 4.7% from 2025-01-31 to 2026-01-31. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
DMAC currently screens at market cap $157.4M. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
Not investment advice. Open the DMAC and WMT stock pages for the full models.
Not investment advice.